What is the success rate of stem cell therapy for diabetes?

The success rate of stem cell treatment for diabetes at DVC stem cell is roughly 80%

Is stem cell good for diabetic patients?

Stem cell can not completely cure diabetes.

Which hospitals is best for stem cell therapy in India?

One of the best stem cell hospital in India is Fortis Hospital, Gurgaon.

Can type 2 diabetes be reversed permanently?

There is no cure for diabetes & no way to completely get rid of it.

Which country is best for stem cell treatment?

South Korea is particularly is noted for its advancements in stem cells treatment.

Stem cell therapy for diabetes in India- Is it safe and effective?

Introduction

Diabetes has emerged as one of the fastest increasing health problems globally, and India is among the nations placed on the list to be worst hit. Ranging from early-onset type 1 diabetes to the most prevalent type 2 diabetes mellitus in adults, the disease has left millions struggling with their health, lifestyle, and even economy. People spend decades on insulin shots, rigorous diets, and so-called best medicine for diabetes, but most of them still do not get a long-term solution. No surprise that scientists and physicians have resorted to new technologies such as stem cell therapy in an effort to find a potential diabetes cure. In India, where type 2 and type 1 diabetes cases are increasing at alarming levels, stem cell research has thrown new light of hope on the face of diabetic patients fed up with traditional ways of treating diabetes. While insulin and drugs manage diabetes, stem cells are actually able to regenerate or repair destroyed pancreatic cells and increase the body's own insulin production, which no pill or shot can ever do. If anyone wants to learn in-depth about the treatment, connect with the best medical professionals in the field.

Background on Diabetes & Stem Cells

To gain a clearer understanding of the relationship between stem cells and diabetes, one should first consider what diabetes is. Diabetes mellitus has always been controlled by the control of hyperglycemia symptoms. If blood glucose increases due to an inability of the pancreas to release sufficient insulin, or resistance of the body to insulin, it causes type 2 diabetes. The immune system demolishes insulin-producing cells in the pancreas in type 1 diabetes. Diabetes 1 and diabetes 2 both lead to serious health ailments if left untreated, such as kidney failure, nerve damage, blindness, and heart disease. Drugs and insulin injections have been championed as the best medication for diabetes for various decades, yet they only regulate blood glucose; they do not treat diabetes.

It is here that stem cells enter the picture. Stem cells have the unique ability to transform into other types of cells, such as insulin-producing pancreatic beta cells. The idea is that if physicians can extract stem cells and teach them to replace faulty pancreatic cells, then type 1 and type 2 diabetes care can progress beyond control of blood sugar—it might even cure the underlying condition. Stem cell therapy has already demonstrated tremendous potential in other diseases, and Indian scientists are thus trying to find out how it might be a game-changer for tens of millions of patients looking for improved control of diabetes and not merely a lifetime reliance on drugs. If one is considering stem cell treatment as a viable treatment option, then one can book an online doctor consultation on our platform in just minutes.

(LEAD FORM)

Types Of Stem Cell Therapies Used

Regarding the cure of diabetes with the help of stem cells, various cells are being tried and experimented with. They work differently, and in India, various research centers and hospitals are engaged in developing them to use the safest and most effective one. The first prominent category is mesenchymal stem cells (MSCs), usually derived from bone marrow, fat tissue, or umbilical cord blood. These cells are highly valued because they have the potential to decrease inflammation and restore pancreatic cells. MSC therapy has been promising for the treatment of type 2 diabetes as well as even in some cases of juvenile diabetes or type 1 diabetes. Another method uses induced pluripotent stem cells (iPSCs), which are derived from reprogramming regular cells to function similar to embryonic stem cells. These iPSCs can be directed to insulin-secreting cells, with promise for a future cure of type 2 diabetes mellitus. Transplants of islet cells are of interest, where recipient islet cells are placed inside a diabetic patient.

This is of particular value to type 1 diabetes therapy, where the patient's own insulin output is virtually zero. India is also researching umbilical cord stem cells as a source, since they are simpler to harvest and cause fewer rejection issues. All these types of stem cells are being studied for safety, stability, and long-term efficacy, and while none can yet be termed the oft-searched solution to diabetes, all are good candidates for something more than medication taken now by type 2 diabetics and insulin therapy patients.

Treatment Procedure In India

The procedure of stem cell therapy for diabetes in India traditionally begins with appropriate screening and diagnosis. Physicians test whether the patient has type 1 or type 2 diabetes, how severe the condition is, and other complications. Once the candidate is identified, stem cells are retrieved from the patient's body (autologous) or donors (allogeneic). In the treatment of type 2 diabetes, stem cells are normally obtained from fat tissue or bone marrow due to their high availability and ease of extraction. Once extracted, the stem cells are processed in high-tech labs where they are cultured and treated for therapy.

The process is necessary since the cells must be enriched and at times directed to form into pancreatic beta-like cells. The second step is transplantation, and that can be accomplished by infusing the treated stem cells into the bloodstream or surrounding the pancreas. The idea is that these cells will travel to the affected pancreas, heal, and begin insulin production. Individuals are monitored for a few days to weeks to determine how their blood glucose level varies and how they react. Indian hospitals began providing this therapy in Delhi, Mumbai, Bangalore, and Hyderabad, and therefore, the country is among the experimental centers for the treatment of diabetes mellitus.

The therapy is performed with strict guidelines, and although it is not officially recognized yet as a treatment for diabetes, it has yielded good results in the majority of real-life cases. The patients who have undergone the therapy most frequently show decreases in insulin and drug consumption for type 2 diabetes, which is a significant improvement in diabetes care. Stem cell doctors in India give best possible treatment which helps to increase the success rate of the treatment.

Stem cell treatment for Diabetes

Effectiveness & Real World Outcomes

Everyone's wondering—is it effective? The truth is that stem cell treatment for type 2 and type 1 diabetes is experimental, but up to now, the outcomes are promising. In most case studies and clinical trials throughout India, those individuals receiving stem cell treatment had an impressive reduction of the signs of high blood sugar. Numerous type 2 diabetes patients suppressed or even discontinued insulin shots for months. In children's diabetes, children receiving stem cells had improved sugar control and reduced reliance on standard diabetes 1 treatment. Results do differ.

While an overwhelming majority of patients have been successful, there were some who didn't notice any change overnight. Age, for how long, and whether one has type 1 or type 2 diabetes mellitus are critical factors that go into deciding the efficacy of the cure. The fact that India already has seen a series of successes, however, is a testament to the potential that stem cells hold for transforming treatment for diabetes in the years to come. As opposed to conventional therapies, stem cells provide not only control but also a route towards a cure for diabetes.

Risks & Limitations

As with any other cutting-edge therapy, there are risks in stem cell therapy for diabetes. The first drawback is that currently, it is not a sure-fire cure for diabetes. While the majority of the patients respond, others fail to respond whatsoever. The second risk factor is immune rejection, particularly when donor stem cells are employed in treatment for type 1 diabetes. Cell abnormality during development, tumor growth, or infection subsequent to the therapy are also issues of concern. Besides medical risk, there are also practical constraints. It is costly and beyond the reach of most Indian health insurance policies.

There remain shifting regulatory guidelines, so not all of the suppliers of the treatment are equally safe. Patients need to exercise discerning judgment in the selection of providers in order to prevent unsubstantiated or dangerous treatments. In short, whereas stem cells are among the most sophisticated and promising technologies to manage type 2 diabetes, they are not yet a full replacement for insulin or any other medication to manage type 2 diabetes. They must be approached by patients as a possibility with promise, but not as assurance.

Stem cell therapy

Treatment Cost In India

The treatment cost of diabetes through stem cells in India is also determined by the clinic, the quality of the stem cells, and the severity of the condition. On average, an average patient would have to pay anything between ₹4 lakhs to ₹12 lakhs for the entire process. It is relatively cheaper than in the US or Europe, where it is three or four times as expensive. But for most Indians, this is still costly, considering that diabetes is a chronic condition.

Cost-determining factors are whether the patient will have to undergo more than one session, the type of laboratory processing employed, and after-care. For type 2 diabetes mellitus, autologous is cheaper because cells are sourced from their own body, but donor cells in juvenile diabetes or type 1 diabetes would be an added expense. While stem cell therapy is expensive, the patient considers it as an investment against the expense of years of type 2 diabetes medication, insulin shots, and doctor visits.

Future Scope Of Treatment

The future of stem cell therapy for diabetes in India appears bright but is in development. Research continues to improve with regard to how stem cells can be pushed more consistently into fully functioning insulin-producing cells. Researchers are also exploring combination therapies, in which stem cells are paired with immunotherapy to avoid loss of new cells in type 1 diabetes treatment.

With India's medical research infrastructure growing and demand for alternate diabetes care, India stands to be at the forefront in clinical application of stem cells. Regulation systems will likely get tighter over the course of the next few years, making treatment safer and more uniform. The price will likely reduce as technology is used with greater frequency, making it accessible to more people.

Summary

Diabetes treatment with stem cells in India is creating a lot of stir as it holds out the hope for something different from the conventional regimen of insulin shots, pills, and constant sugar monitoring. Diabetes has been an issue of controlling blood sugar symptoms instead of the actual problem. Whether it is type 1 diabetes because of an autoimmune attack on pancreatic cells or type 2 diabetes mellitus where the body is resistant to insulin, the reality is that no type 2 diabetes medicine currently available or diabetes 1 treatment provides a cure for diabetes. Stem cells bring promise because they can be made into insulin-producing cells and actually restore normal function to the pancreas.

India has become a strong base for such experimental therapies, with hospitals in metro towns offering different treatments at costs below the West. Initial results are promising, with reduced dependence on the best medicine against diabetes, better regulation of sugar in type 2 diabetes patients, and even reversal in certain cases of juvenile diabetes. But stem cell therapy is still in trial stages, so risks, limitations, and unforeseen outcomes are very real. In the years to come, as technology advances and costs come down, stem cells can transform the treatment of diabetes in India, bringing patients one step closer to a cure that addresses the root, not just controls the symptom.